Live Breaking News & Updates on Therapeutics Reports Full Year

Stay updated with breaking news from Therapeutics reports full year. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Call To Action: Eradicating Cervical Cancer Through Innovation And Investment

An open letter by cervical cancer tech startups, Amplexd Therapeutics, Ananya Health, and Mission-Driven Tech, call for the innovation, research, and investment. ....

Daniel-burnett , Onyinye-balogun , Julie-yip , World-health-organization , Ananya-health , Amplexd-therapeutics , Mission-driven-tech , Cervical-cancer-elimination , Pap-testing , Anu-parvatiyar , Driven-tech , Eve-mcdavid

UK and US Announces Partnership to Tackle Biological Threats For Future Pandemics

A new biological threat-tackling partnership has been formed between the UK and the US building on the Atlantic Declaration signed last year to strengthen biosecurity surveillance like disease ....

United-states , United-kingdom , Britain , America , Ian-abbs , Michelle-donelan , Oliver-dowden , United-kingdom-cabinet-office , White-house-national-security-council , Atlantic-declaration , Strategic-dialogue , Biological-security

Bristol Myers Squibb to buy Karuna Therapeutics for $14bn

Biopharmaceuticals giant Bristol Myers Squibb has announced it is spending $14bn to purchase Karuna Therapeutics, which develops treatments for people living with psychiatric and neurological conditions. ....

Christopher-boerner , Dow-jones , Mizuho-securities , Cereval-therapeutics , Bristol , Myers , Squibb , Karuna , Therapeutics , R4bn , Category-all , Category-company-news

When Will Vivoryon Therapeutics N.V. (AMS:VVY) Turn A Profit?

With the business potentially at an important milestone, we thought we'd take a closer look at Vivoryon Therapeutics. ....

Management-team , Vivoryon-therapeutic , Vivoryon-therapeutics , Simply-wall , Track-record , High-performing-stocks , Therapeutics , Rowth-rate ,

C-Path's TRxA and Celdara Medical announce MOU to identify and advance promising new therapeutics

Critical Path Institute's (C-Path) Translational Therapeutics Accelerator (TRxA) and Celdara Medical today announced the signing of a Memorandum of Understanding (MOU) aimed at identifying and advancing promising new therapeutics in areas of high unmet medical need. ....

Julie-coleman , Jake-reder , Maaike-everts , Critical-path-institute-translational-therapeutics-accelerator-trx , Critical-path-institute , Path-institute , Translational-therapeutics-accelerator , Celdara-medical , Chief-executive-officer , Executive-director , Therapeutics , Iotechnology